News | Latest Breaking News Stories & Headlines

Novo Nordisk, which currently has 78,400 positions globally, said about 5,000 of the job cuts will be in its native Denmark

Novo Nordisk slashes 9,000 jobs to slim down operations

Wegovy-maker Novo Nordisk will cut 9,000 jobs, or about 11.5% of its workforce, in a restructuring to save 8 billion Danish crowns ($1.26 billion) annually, it said today, as it battles rising pressure from US rival Eli Lilly.

Business • 10 Sep

Lars Fruergaard Jorgensen, the outging CEO of Novo Nordisk

Novo Nordisk's CEO to step down amid market struggle

Wegovy and Ozempic-maker Novo Nordisk said today its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

Business • 16 May

Novo Holdings is the controlling shareholder of obesity drugmaker Novo Nordisk

Novo Holdings doubles income and returns in 2024

Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment returns to a record €8 billion in 2024, it said today.

Business • 02 Apr

Breeda O'Donoghue died from total organ failure after taking Ozempic, which led to daily vomiting episodes

'Profound vomiting' after Ozempic led to woman's death

An inquest in Cork has been told that a 66-year old woman died from "profound vomiting" brought on by the drug Ozempic, which she had been prescribed to help her lose weight.

Health • 30 Jan

Walmart's data shows that customers who fill a Ozempic prescription also buy less food than average

Profit & weight loss: How Ozempic is disrupting business

Ozempic and Wegovy have been shown to have a dramatic impact on users', and their success is up-ending multiple industries too, writes Adam Maguire.

Business • 18 Jul 24

In December, the Irish arm of Novo Nordisk lodged plans with South Dublin County Council for a new filling and packaging facility at Grange Castle Business Park West

Council seeks new plans from Novo Nordisk on Dublin plant

The maker of 'blockbuster' weight loss and diabetes drug, Ozempic, Novo Nordisk has been requested to lodge revised plans for its large scale Dublin plant arising from local residents' concerns.

Business • 26 Feb 24

Semaglutide is the active substance used in medicines such as Ozempic, Rybelsus, and Wegovy

Regulator seizes 254 units of 'falsified' diabetes drug

The Health Products Regulatory Authority has said that 254 units of falsified Semaglutide have been detained in Ireland so far this year.

Health • 25 Oct 23

Europe's medicines regulator has warned about pre-filled pens falsely labelled as Ozempic (Stock image)

People hospitalised in Austria over supect fake Ozempic

Several people were taken to hospital in Austria after using suspected counterfeits of the diabetes drug Ozempic, according to the federal health safety office.

World • 24 Oct 23

Novo stops Ozempic kidney trial after signs of success

Novo Nordisk has said it will stop a trial studying Ozempic to treat kidney failure in diabetes patients ahead of schedule because it was clear from an interim analysis that the treatment would succeed.

Business • 11 Oct 23

Surging demand for Wegovy and Novo's diabetes drug Ozempic, have sent the company's shares and earnings to record highs

Novo Nordisk launches weight-loss drug Wegovy in UK

Novo Nordisk has today launched its weight-loss injection Wegovy in Britain, its second debut in Europe in just over a month as the drugmaker seeks to expand in the region even as it struggles to keep up with soaring demand.

Business • 04 Sep 23

Ozempic